A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
Clinical trial NCT03952559 · COMPLETED
Trial details
- NCT number
- NCT03952559
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-24
- Primary completion
- 2022-04-24
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.